Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
Authors
Keywords
-
Journal
iScience
Volume 24, Issue 9, Pages 103006
Publisher
Elsevier BV
Online
2021-08-20
DOI
10.1016/j.isci.2021.103006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
- (2021) Michael J. Joyner et al. NEW ENGLAND JOURNAL OF MEDICINE
- New mutations raise specter of ‘immune escape’
- (2021) Kai Kupferschmidt SCIENCE
- Viral evolution may herald new pandemic phase
- (2021) Kai Kupferschmidt SCIENCE
- Fast-spreading U.K. virus variant raises alarms
- (2021) Kai Kupferschmidt SCIENCE
- Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
- (2021) Yunjiao Zhou et al. Cell Reports
- Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
- (2021) Emanuele Andreano et al. CELL
- Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
- (2021) Aurélien Sokal et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- Convalescent plasma and hyperimmune globulin therapy in COVID-19
- (2021) Deniz Cagdas Expert Review of Clinical Immunology
- SARS-CoV-2 Viral Variants—Tackling a Moving Target
- (2021) John R. Mascola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunodominant antibody germlines in COVID-19
- (2021) Emanuele Andreano et al. JOURNAL OF EXPERIMENTAL MEDICINE
- SARS-CoV-2 variants and ending the COVID-19 pandemic
- (2021) Arnaud Fontanet et al. LANCET
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report
- (2021) Kai Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
- (2021) Sabari Nath Neerukonda et al. PLoS One
- The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
- (2021) Arturo Casadevall et al. mBio
- Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients
- (2021) Juanjie Tang et al. Nature Communications
- Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution
- (2021) Supriya Ravichandran et al. Science Advances
- SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities
- (2021) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Diverse Functional Autoantibodies in Patients with COVID-19
- (2021) Eric Y. Wang et al. NATURE
- The emerging plasticity of SARS-CoV-2
- (2021) Kevin D. McCormick et al. SCIENCE
- Brief report: Production of anti‐SARS‐CoV ‐2 hyperimmune globulin from convalescent plasma
- (2021) Peter Vandeberg et al. TRANSFUSION
- SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
- (2021) Andrew G Letizia et al. Lancet Respiratory Medicine
- Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine Design
- (2020) Surender Khurana et al. Cell Host & Microbe
- Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
- (2020) Daniel Wrapp et al. CELL
- Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
- (2020) Supriya Ravichandran et al. Science Translational Medicine
- SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
- (2020) Nicholas C. Wu et al. Cell Reports
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for COVID-19 Convalescent Plasma
- (2020) Roxie C Girardin et al. JOURNAL OF INFECTIOUS DISEASES
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
- (2019) Richard T Davey et al. Lancet Respiratory Medicine
- Antigenic fingerprinting of RSV-A infected hematopoietic cell transplant recipients reveals importance of mucosal anti-RSV-G antibodies in control of RSV infection in humans
- (2019) Sandra Fuentes et al. JOURNAL OF INFECTIOUS DISEASES
- AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
- (2018) Surender Khurana et al. npj Vaccines
- Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins
- (2016) Sandra Fuentes et al. PLoS Pathogens
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
- (2009) Surender Khurana et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now